Saxagliptin Attenuates Thioacetamide-Induced Liver Fibrosis in Rats in Association with Changes in SIRT1/Nrf2/HO-1 Signaling, Oxidative Stress, and Apoptosis.
Oct 2026· Toxicology Mechanisms and Methods· pp.
1-18
· 0 citations· 53 references
Medicine
TL;DR
Saxagliptin was associated with attenuation of TAA-induced hepatic fibrosis and improvements in oxidative stress, inflammation, apoptosis, and fibrosis-related signaling, consistent with involvement of SIRT1- and Nrf2/HO-1-associated cytoprotective responses but do not establish pathway causality.
Abstract
Purpose
Currently, no universally effective treatment exists to stop or reverse the development of liver fibrosis. Saxagliptin (SAX), a dipeptidyl peptidase-4 (DPP-4) inhibitor, has demonstrated extra-glycemic benefits, including anti-inflammatory and anti-apoptotic properties, but its role in hepatic fibrogenesis has not been characterized. This study examined the protective potential and underlying mechanisms of saxagliptin against thioacetamide (TAA)-induced hepatic fibrogenesis in rats.
Methods
Twenty-four male Wistar rats were randomly allocated to four groups: control, TAA-induced fibrosis, TAA + saxagliptin (5 mg/kg), and TAA + saxagliptin (10 mg/kg). Biochemical, molecular, and histopathological analyses were conducted to assess liver injury, lipid profile, oxidative stress, inflammatory and fibrotic markers, apoptosis, and key cytoprotective signaling pathways.
Results
TAA induced significant liver injury, oxidative stress, inflammation, apoptosis, and fibrosis, together with suppression of SIRT1 and Nrf2/HO-1 pathways. Saxagliptin was associated with improvements in hepatotoxicity, dyslipidemia, oxidative-stress, inflammatory, apoptotic, and fibrosis-related parameters, together with increased SIRT1 and Nrf2/HO-1 protein levels. The higher dose generally produced greater numerical improvement across several endpoints. Histopathological and immunohistochemical analyses showed reduced fibrosis-related changes and α-SMA immunoreactivity, with the higher dose (10 mg/kg) associated with hepatic architecture and fibrosis scores approaching the control findings.
Conclusion
Saxagliptin was associated with attenuation of TAA-induced hepatic fibrosis and improvements in oxidative stress, inflammation, apoptosis, and fibrosis-related signaling. These findings are consistent with involvement of SIRT1- and Nrf2/HO-1-associated cytoprotective responses but do not establish pathway causality. Further mechanistic studies are required to determine whether these pathways are necessary for the observed effects.
Abstract Objective Liver fibrosis is a progressive consequence of chronic injury with limited treatment options. Vildagliptin (Vilda), a dipeptidyl peptidase-4 inhibitor, possesses antioxidant and anti-inflammatory properties, but its effects on thioacetamide (TAA)-induced liver fibrosis are not fully characterized. Th...
Mohannad A. Almikhlafi, May A. Alsayb, Sara A. Almadani et al.· Immunopharmacology and immun...· 0 citations
Background: Nonalcoholic fatty liver disease (NAFLD) and liver fibrosis are major health concerns globally, especially in patients with type 2 diabetes mellitus (T2DM). Dysregulated insulin signaling and chronic inflammation are central to disease progression. Objective: This study evaluates the hepatoprotective and an...
Shikha Goswami, R. Goyal· International Journal of Dru...· 0 citations
Background Prolonged or high dexamethasone (DEXA) exposure can promote steatohepatitis-like liver injury through insulin resistance, oxidative stress, inflammation, mitochondrial dysfunction, and fibrosis. Sacubitril/valsartan (Entresto) exhibits metabolic, anti-inflammatory, and antifibrotic properties that may protec...
Mutni Kh. Alreshidi, Karim M. Saad, Marwa S. Zaghloul et al.· Frontiers in Pharmacology· 0 citations
ABSTRACT Aims/Introduction Oxidative stress is thought to play a role in the onset and progression of diabetic nephropathy (DN). Nuclear factor erythroid‐related factor 2 (Nrf2) is a master regulator of antioxidant and detoxification pathways and provides cellular protection against oxidative stress. This study aimed t...
S. Promsuwan, Y. Takiyama, Takao Takiyama et al.· Journal of Diabetes Investig...· 0 citations
The present study aimed to investigate the potential protective effect of rivastigmine (RIVA) against doxorubicin (DOX)-induced ovarian injury in female rats, with particular emphasis on its anti-inflammatory, antioxidant, and antiapoptotic effects. Thirty-two adult female albino rats were randomly divided into four gr...
Walaa Yehia Abdelzaher, M. Hassan, M. Attya et al.· Reproductive Toxicology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.